Accuray's Upcoming Financial Announcement
Accuray Incorporated (NASDAQ: ARAY) is gearing up to report its financial results for the second quarter of fiscal year 2026. This pivotal event will take place during a conference call with company management scheduled for February 4, 2026, at 1:30 p.m. PT/4:30 p.m. ET. Investors and stakeholders are eagerly anticipating insights into the company’s performance during the second quarter, which concluded on December 31, 2025.
Details of the Conference Call
For those interested in participating, the conference call can be accessed through specific dial-in numbers provided by Accuray. In the USA, the number is 1-833-316-0563, while international callers can reach the call at 1-412-317-5747. After the call, a replay will be available approximately one hour post-conclusion, allowing stakeholders to catch up on what they may have missed. USA listeners can reach the replay at 1-855-669-9658; international participants should use 1-412-317-0088 with conference ID: 8587254. This setup ensures that everyone has the opportunity to stay updated.
Webcast Availability
In addition to the audio call, Accuray will be providing a live webcast of the event. This can be accessed through the Investor Relations section of the company’s website, which is designed to provide comprehensive information to its investors. A recorded version of the webcast will also be available online, accessible until the company announces its financial results for the third quarter of fiscal 2026.
About Accuray and Its Commitment
Accuray is dedicated to pushing the boundaries of radiation therapy and seeks to enhance the quality of life for patients. With a focus on continuous innovation, the company aims to provide advanced and effective solutions for diverse patient needs in oncology, neuro-radiosurgery, and beyond. By developing cutting-edge treatments, Accuray collaborates closely with clinicians and healthcare administrators, enabling them to deliver high-quality care efficiently and effectively.
Engaging with Accuray
The mission of Accuray goes beyond merely supplying radiation therapy systems. The company is committed to improving treatment accessibility and simplifying procedures, particularly for complex medical cases. This dedication is reflected in their strategic partnerships and innovative practices aimed at empowering medical professionals, and ultimately, aiding patients in their recovery journeys. With its headquarters in Madison, Wisconsin, and various global facilities, Accuray continuously strives to lead in the field of radiotherapy.
Company Contacts
For investor inquiries, individuals can reach out to Aman Patel, CFA, who oversees Investor Relations at ICR Healthcare. Accuray also maintains a media contact, Steve Monroe, VP of Financial Planning & Analysis. Both representatives are available to address questions and provide further details about the company’s direction and upcoming initiatives.
Frequently Asked Questions
When will Accuray announce its second-quarter results?
Accuray is set to report its second-quarter fiscal results on February 4, 2026, during a conference call.
How can I participate in the conference call?
You can join the conference call by dialing 1-833-316-0563 in the USA or 1-412-317-5747 internationally.
Will there be a replay of the conference call?
Yes, a replay will be available approximately one hour after the call concludes, lasting for a week.
Is there a webcast for the conference call?
Yes, a live webcast can be accessed through Accuray's Investor Relations section, with a recorded version available after the event.
Who can I contact for more information?
Aman Patel, CFA, handles investor relations, while Steve Monroe is available for media inquiries.
